Quick Answer
Alto Neuroscience, Inc. reported Operating Income of -$66.36 million for fiscal year 2025.
Alto Neuroscience, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$66.36M | +3.3% |
| 2024 | -$68.61M | -81.5% |
| 2023 | -$37.81M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$14.95M | +20.8% | +20.0% |
| June 30, 2025 | -$18.68M | -1.9% | -19.2% |
| March 31, 2025 | -$15.68M | -9.0% | +17.0% |
| September 30, 2024 | -$18.89M | -94.3% | -3.0% |
| June 30, 2024 | -$18.34M | -101.0% | -27.5% |
| March 31, 2024 | -$14.39M | -99.8% | -48.0% |
| September 30, 2023 | -$9.72M | — | -6.5% |
| June 30, 2023 | -$9.12M | — | -26.7% |
- Alto Neuroscience, Inc. showed an increase of +3.3% in Operating Income compared to the prior fiscal year.
- Over the 2023–2025 period, Alto Neuroscience, Inc.’s operating income has declined by 75.5% (from -$37.81 million to -$66.36 million).
- The most recent figure is from Alto Neuroscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: